{Reference Type}: Journal Article
{Title}: Urinary Tract Cytopathology: Current and Future Impact on Patient Care.
{Author}: Jorda M;Kryvenko ON;Hanly F;Zuo Y;
{Journal}: Surg Pathol Clin
{Volume}: 17
{Issue}: 3
{Year}: 2024 Sep
暂无{DOI}: 10.1016/j.path.2024.06.001
{Abstract}: Urine cytology is a non-invasive, cost-efficient, and sensitive test to detect high-grade urothelial carcinoma. The Paris System (TPS) for Reporting Urinary Cytology is an evidence-based system that uses the risk of malignancy to guide patient management. Since its inception, TPS has standardized urine cytology reports, facilitating communication among pathologists and between pathologists and clinicians. It is imperative to correlate the urine cytology findings with the concurrent tissue sample to avoid false-negative and false-positive results when possible. Several ancillary tests and artificial intelligence algorithms are being developed to increase the accuracy of urine cytology interpretation.